Buy SLU-PP-332 (250mcg x 100 Tablets) Research Capsules OnlineSLU-PP-332 (250mcg x 100 Tablets) Product Specifications & StorageA tablet-formulated delivery of SLU-PP-332 at 250 microgram unit doses per tablet across 100-count supply, this preparation targets preclinical research requiring precise dosing with extended storage stability. The selective estrogen-related receptor agonist compound maintains pharmacological activity within compressed tablet matrices optimized for oral administration in rodent research models. This lower-dose tablet configuration enables dose-escalation protocols and flexible dosing strategies across multiple experimental cohorts.SLU-PP-332 (250mcg x 100 Tablets) Mechanism of ActionThe mechanism involves selective ERRα and ERRγ nuclear receptor agonism, engaging transcriptional pathways distinct from classical estrogen signaling in laboratory animal metabolic tissues. Preclinical studies document tablet-formulated SLU-PP-332 achieving effective drug delivery and target receptor engagement in rodent mitochondrial biogenesis and metabolic studies. The 250 microgram tablet dosage provides half-unit scaling relative to standard 500 microgram capsule preparations, supporting gradient dose-response investigations.SLU-PP-332 (250mcg x 100 Tablets) Published Research SummaryPeer-reviewed research characterizes tablet formulation pharmacokinetics and dissolution kinetics in simulated gastric fluid, establishing bioavailability parameters in rodent absorption studies. Preclinical investigations document plasma concentrations and tissue distribution following oral tablet administration. Animal studies demonstrate that tablet delivery achieves comparable ERR receptor engagement and metabolic outcomes to other formulation approaches, validating tablet utility for research applications.The 100-tablet container facilitates extended experimental periods in chronic dosing protocols examining metabolic adaptation and mitochondrial function modulation. Individual tablet separation permits precise daily dosing via forced oral administration standard in rodent research. Tablets accommodate flexible scheduling including escalating-dose protocols.Storage requires room temperature (20-25°C) in dry conditions protected from light and humidity. Tablets demonstrate extended shelf stability under appropriate storage conditions. All usage requires documentation per institutional guidelines.SLU-PP-332 (250mcg x 100 Tablets) Research Use Only DisclaimerDISCLAIMER: Exclusively for preclinical research and educational purposes. Not for human consumption, therapeutic intervention, or medical application. All documented effects from animal models exclusively. Institutional compliance and regulatory requirements mandatory.
